CTSG was reported as a potential immune-related biomarker in OSCC by a recent study [23], and it has also been found to be associated with the survival of other cancer types such as soft tissue sarcoma [24], muscle-invasive bladder cancer [25], and node-negative breast cancer [26]. This evidence concerns the gene CTSG and cancer.